Literature DB >> 9262931

Contraceptive use in women with bacterial vaginosis.

M Shoubnikova1, D Hellberg, S Nilsson, P A Mårdh.   

Abstract

The aim of the study was to investigate if bacterial vaginosis (BV) is associated with use of specific contraceptives. Women at family planning and youth clinics (n = 956), among whom 131 had BV, were subjects for structured in-depth interviews including current and previous contraceptive use. Variables measuring sexual risk-taking were ascertained. Current users of contraceptives were compared with non-users. Both oral contraceptive (OC) and condom use showed a significant protective effect against BV, adjusted for possible confounders (odds ratios were 0.4 and 0.3, respectively). Intrauterine device use (IUD) showed no association with BV. Women with BV had less often used any contraceptives, including condom, at their sexual debut than the women in the comparison group. In this study, OC and condom use seemed to exert a protective effect against BV, whereas no effect for IUD use was found.

Entities:  

Keywords:  Bacterial And Fungal Diseases; Barrier Methods--beneficial effects; Biology; Condom--beneficial effects; Contraception; Contraceptive Methods--beneficial effects; Correlation Studies; Developed Countries; Diseases; Europe; Family Planning; Infections; Northern Europe; Oral Contraceptives--beneficial effects; Research Methodology; Research Report; Risk Factors; Scandinavia; Statistical Studies; Studies; Sweden; Vaginal Abnormalities--etiology

Mesh:

Substances:

Year:  1997        PMID: 9262931     DOI: 10.1016/s0010-7824(97)00044-9

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  22 in total

1.  Factors linked to bacterial vaginosis in nonpregnant women.

Authors:  C Holzman; J M Leventhal; H Qiu; N M Jones; J Wang
Journal:  Am J Public Health       Date:  2001-10       Impact factor: 9.308

2.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

3.  Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinics.

Authors:  L Brabin; S A Roberts; E Fairbrother; D Mandal; S P Higgins; S Chandiok; P Wood; G Barnard; H C Kitchener
Journal:  Sex Transm Infect       Date:  2005-12       Impact factor: 3.519

4.  The burden and determinants of reproductive tract infections in India: a population based study of women in Goa, India.

Authors:  V Patel; H A Weiss; D Mabey; B West; S D'Souza; V Patil; P Nevrekar; S Gupte; B R Kirkwood
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

5.  Risk factors for bacterial vaginosis: results from a cross-sectional study having a sample of 53,652 women.

Authors:  X-D Li; C-C Wang; X-J Zhang; G-P Gao; F Tong; X Li; S Hou; L Sun; Y-H Sun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-23       Impact factor: 3.267

6.  Effects of intrauterine contraception on the vaginal microbiota.

Authors:  Christine M Bassis; Jenifer E Allsworth; Heather N Wahl; Daniel E Sack; Vincent B Young; Jason D Bell
Journal:  Contraception       Date:  2017-06-15       Impact factor: 3.375

7. 

Authors:  Natividad Chávez; Helfer Molina; Jorge Sánchez; Bizu Gelaye; Sixto E Sánchez
Journal:  Rev Peru Med Exp Salud Publica       Date:  2009-01-01

8.  Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study.

Authors:  Tessa Madden; Jaclyn M Grentzer; Gina M Secura; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2012-03       Impact factor: 2.830

9.  Social and sexual risk factors for bacterial vaginosis.

Authors:  S Smart; A Singal; A Mindel
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

Review 10.  The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.

Authors:  Sharon L Achilles; Sharon L Hillier
Journal:  AIDS       Date:  2013-10       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.